EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Metabolic immunoengineering approaches to enhance CD8+ T cell-based cancer immunotherapy

Bing Feng, Rongrong Li, Weilin Li, Li Tang

Cell Systems · 2024-12 · 15 (12) · 1225-1244

DOI: 10.1016/j.cels.2024.11.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Systems, 2024-12. Verfasst von Bing Feng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland; Institute of Materials Science & Engineerin…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Neoplasms, Immunotherapy, Tumor Microenvironment. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Anna Fuller Fund, École Polytechnique Fédérale de Lausanne, Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many cancer immunotherapies rely on robust CD8+ T cells capable of eliminating cancer cells and establishing long-term tumor control. Recent insights into immunometabolism highlight the importance of nutrients and metabolites in T cell activation and differentiation. Within the tumor microenvironment (TME), CD8+ tumor-infiltrating lymphocytes (TILs) undergo metabolic adaptations to survive but compromise their effector function and differentiation. Targeting metabolism holds promise for enhancing CD8+ T cell-mediated antitumor immunity. Here, we overview the metabolic features of CD8+ TILs and their impact on T cell effector function and differentiation. We also highlight immunoengineering strategies by leveraging the Yin-Yang of metabolic modulation for improving cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesNeoplasmsImmunotherapyTumor MicroenvironmentLymphocytes, Tumor-InfiltratingHumansAnimalsCell Differentiation

Stichwörter der Autor:innen

CD8(+) T cellcancer immunotherapymetabolic immunoengineering

Autor:innen und Institutionen

  • Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland; Institute of Materials Science & Engineering, EPFL, 1015 Lausanne, Switzerland.
  • Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
  • Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland; Institute of Materials Science & Engineering, EPFL, 1015 Lausanne, Switzerland. Electronic address: li.tang@epfl.…

Förderung

  • The Anna Fuller Fund
  • École Polytechnique Fédérale de Lausanne
  • Swiss National Science Foundation

Zitieren

APA

Feng, B., Li, R., Li, W., & Tang, L. (2024). Metabolic immunoengineering approaches to enhance CD8+ T cell-based cancer immunotherapy. Cell Systems, 15(12), 1225-1244. https://doi.org/10.1016/j.cels.2024.11.010

Vancouver

Feng B, Li R, Li W, Tang L. Metabolic immunoengineering approaches to enhance CD8+ T cell-based cancer immunotherapy. Cell Systems. 2024;15(12):1225-1244. doi:10.1016/j.cels.2024.11.010

BibTeX
@article{Feng2024,
  author = {Feng, Bing and Li, Rongrong and Li, Weilin and Tang, Li},
  title = {Metabolic immunoengineering approaches to enhance CD8+ T cell-based cancer immunotherapy},
  journal = {Cell Systems},
  year = {2024},
  volume = {15},
  number = {12},
  pages = {1225--1244},
  doi = {10.1016/j.cels.2024.11.010}
}
Kostenlos starten →